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Understanding, screening, and providing resources for quality of life factors and 
psychosocial distress have become an important area of focus in cancer care. Negative 
consequences of poor quality of life and psychosocial distress have been widely studied in 
oncological research. The National Comprehensive Cancer Network, or NCCN, defines 
“psychosocial distress” as extending on a continuum, “ranging from common normal feelings of 
vulnerability, sadness, and fears to problems that can become disabling, such as depression, 
anxiety, panic, social isolation, and existential and spiritual crisis” (“National Comprehensive 
Cancer Network,” n.d.). Findings have indicated the significant impact of poor quality of life and 
psychosocial distress in the cancer patient population. Elevated levels of psychosocial distress 
increases the risk of developing depression, anxiety, immune suppression, and may lead to high 
levels of stress. Studies have also revealed associations between increased psychosocial distress 
levels, relapse, treatment and healing outcomes, and survival rates (Anderson, Kiecolt-Glaser, & 
Glaser, 1994; Spiegel & Nemeroff, 1997). Evidence also shows that heightened psychosocial 
distress negatively influences a patient’s capability to adhere to their medical plan and treatment 
(Allison et al., 1995; Pirl et al., 2007; Zabora, Brintzenhofeszoc, Curbow, Hooker, & Piantadosi, 
2001). Attending to these negative outcomes of psychosocial distress and providing supportive 
care is a crucial action of oncology practice today. The American College of Surgeons 
Commission on Cancer responded to the imperative of addressing psychosocial needs in cancer 
care by mandating national cancer centers for accreditation purposes to screen for psychosocial 
distress and provide appropriate referral and resources (Standard 3.2). UF Health Cancer Center 
– Orlando Health began psychosocial distress screening on January 1
st
, 2015 with the utilization 
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of the Web-based, HIPPA compliant, and action based Cancer Support Source Program. Patient 
data responses collected with the Cancer Support Source Program over the first calendar year of 
the implementation of the American College of Surgeons Commission on Cancer standards were 
analyzed for this research study.  
A sample of 317 patient data responses was included to conduct an exploratory factor 
analysis (EFA) on the Cancer Support Source Program test items. Specifically, a Principal 
Component Analysis (PCA) with an oblique rotational procedure (Promax) was conducted on the 
resulting data set for interpretation. Factorial interpretation was made to ascertain latent 
dimensions in the Cancer Support Source Program. A five factor structure model was found with 
adequate discriminant and face validity. Factors were grouped by conceptual basis and item-
loading composition: Distress, Treatment Management and Decisions, Lifestyle, Relationship, 
and Substance Use.  These factors were collectively termed the Concern Subscales.  
The Distress, Treatment Management and Decisions, and Lifestyle Factors were found to 
present the most psychometrically sound and internally consistent model. Further analysis was 
conducted to examine the resulting factorial structure model on four cancer location groups: 
breast, head and neck, lung, and gynecological cancer. Results displayed that no significant 
differences were found between cancer location groups and the five extracted factors. However, 
an ad hoc test (Tukey’s HSD) revealed two significant differences between the Lifestyle Factor 
and cancer location groups at the p < 0.05 level. The Breast Cancer group’s Lifestyle scores were 
higher than the Gynecologic Cancer group, and the Breast Cancer group scores were lower than 
the Lung Cancer group.  
Additionally, the action scores were summed to examine correlation between the five 
extracted Concern Subscales. A high correlation was found, indicating that the action items in 
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the Cancer Support Source questionnaire correspond with the extracted Concern Subscales and 
do not need to undergo dimension reduction. Furthermore, a high correlation was also found with 
the extracted Distress Concern Subscale and the existing depression subscale in the Cancer 
Support Source Program. 
Results indicated that the Cancer Support Source Program could indeed benefit from 
dimension reduction to ascertain more parsimonious areas of need presented by the cancer 
patient population. The 25 single-items in the Cancer Support Source questionnaire may inhibit 
the ability to indicate other concerns that may be expressed by the patient. By identifying the 
latent dimensions in this exploratory endeavor, we were able to demonstrate how the Cancer 
Support Source questionnaire could be refined to include easily scored Concern subscales to 
better identify areas of need for each individual patient that is screened for psychosocial distress.  
These findings provide an opportunity to impact patient care, opportunities for referral, and 
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CHAPTER ONE: INTRODUCTION 
Quality of life and psychosocial issues have been identified as important areas of need in 
cancer care.   Research has indicated that the presence of psychosocial distress has significant 
negative effects on an individual’s quality of life and emotional, physical, and functional 
domains (Adler & Page, 2008; Carlson et al., 2004; & Institute of Medicine [IOM], 2007). The 
best ways to address this gap in oncology has been a topic for debate in the last two decades. The 
goal of high-quality integrated cancer care and the need for related support services has given 
rise to newly implemented accreditation standards and guidelines for oncological care. These 
guidelines specify the need  to assess, measure, and address quality of life and psychosocial 
distress issues to optimize and prioritize patient treatment plans (American College of Surgeons 
Commission on Cancer, 2012). 
Research exists on a variety of quality of life and psychosocial assessment tools to 
examine and measure potential areas for referrals, intervention, risk assessment, and supportive 
services for cancer patients (Vodermaier, Linden, & Siu, 2009). Furthermore, investigations of 
psychometric properties of these measures display strengths and limitations in their ability to 
identify and differentiate individuals at risk and in need of additional services (Buzaglo, Miller, 
Gayer, Morris, & Golant, 2013). However, psychometric research is limited on a newly created 
Web-based psychosocial distress screening program: the Cancer Support Source Program. An 
exploratory factor analysis (EFA) has the potential to extend the development and utility of this 
instrument. We will be investigating and addressing the empirical research question of the factor 
groupings of test items in the Cancer Support Source Program.  
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CHAPTER TWO: LITERATURE REVIEW 
General Introduction to Quality of Life 
Investigating the nature, conceptualization, and delineation of quality of life in health has 
been an empirical topic in research literature. The concept of quality of life encompasses 
multiple facets of an individual’s life and becomes particularly relevant when analyzed in the 
context of health and, more specifically, a cancer diagnosis. Recently, there has been a 
heightened focus on quality of life (QOL) and health, research examining the impact of health 
related conditions on well-being in physical, social, cognitive, and emotional domains. Quality of 
life in patients with cancer plays a pivotal role in their treatment and management of cancer-
related symptoms: it impacts physical, social, cognitive, and psychological domains. Some 
common physical symptoms patients experience are pain, fatigue, nausea, vomiting, and loss of 
appetite (Aaronson et al., 1993; Pandey, Dhungana, Twi, Byanju, & Khawas, 2015). Impairment 
in social functioning, occupational and financial disruptions, diminishment in cognitive ability, 
and psychosocial distress are also QOL indicators.  Researchers are particularly cognizant of the 
impact QOL can have on a patient during their cancer experience, noting the significant role it 
plays on treatment outcomes, survival, and relapse rates. There is emerging evidence that 
improved QOL is associated with marginally extended survival rates (Pandey, Dhungana, Twi, 
Byanju, & Khawas, 2015). Research has shown quality of life factors play a direct role in how 
patients adhere to their treatment plan and make health care decisions. Stage of cancer, cancer-
related symptoms, acceptance, and psychosocial distress are specific ways that the expression of 
cancer can impact QOL (Heydarnejad, Hassanpour, & Solati, 2011). Oncologists are also 
increasingly becoming more aware of addressing QOL factors in their patients. One study 
examined 260 oncologists and 80% agreed that QOL information should be obtained from their 
3 
 
patients (Bottomley, 2002). The importance of recognizing QOL in tandem with cancer care has 
resulted in the formation and implementation of assessment measures to examine the impact 
treatment has on cancer care. Evaluating quality of life and health-related issues can help 
improve health care by “bridging boundaries between disciplines and between social, mental, 
and medical services” (Centers for Disease Control and Prevention [CDC], 2016). This is also a 
testament to the importance of integrative and multidisciplinary care in healthcare institutions.  
An Overview of Psychosocial Distress 
Assessing and understanding psychosocial distress has become a high priority area of 
interest in cancer care and in the empirical oncologic literature. Recently, there has been a 
greater emphasis on assessing in the treatment, management of care, and screening of patients 
with cancer in hospital settings. While the topic of quality of life encompasses various 
psychosocial distress symptoms, the National Comprehensive Cancer Network (NCCN) has 
provided its own more specific definition of psychosocial distress. NCCN defines “psychosocial 
distress” as extending on a continuum, “ranging from common normal feelings of vulnerability, 
sadness, and fears to problems that can become disabling, such as depression, anxiety, panic, 
social isolation, and existential and spiritual crisis” (“National Comprehensive Cancer Network,” 
n.d.). Furthermore, the NCCN emphasizes how psychosocial distress may impede the patient’s 
ability to effectively cope with a cancer diagnosis, physical cancer-related symptoms, and 
treatment (Phillips, 2009). The prevalence and presence of psychosocial distress in the cancer 
population has received considerable attention in recent years. It has been empirically recognized 
as a stable and substantial problem, and findings indicate that approximately 30% to 40% of 
cancer patients will endure elevated levels of psychosocial distress during their cancer course 
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(Carlson et al., 2004). One third of cancer survivors will experience persistent cancer-related 
fatigue and deteriorating mental health and well-being following a cancer diagnosis (Carlson et 
al., 2004; Costanzo, Ryff, Singer, & Burton, 2009; Escalante, Hesketh, & Savarese, 2013). 
Consequences of distress can cause disability across multiple life domains. Patients suffering 
from cancer and with lower quality of life may be more likely to engage in at-risk behaviors and 
less likely to adhere to health protection behaviors that may promote their well-being and reduce 
stress. Evidence also shows that heightened psychosocial distress negatively influences a 
patient’s capability to adhere to their medical plan and treatment (Allison et al., 1995; Pirl et al., 
2007; Zabora, Brintzenhofeszoc, Curbow, Hooker, & Piantadosi, 2001). Elevated levels of 
psychosocial distress also increase the risk of developing depression, anxiety, immune 
suppression, and may lead to high levels of stress. Chronic stress, a continuous activation of the 
sympathetic nervous system, leads to elevated levels of stress hormones such as norepinephrine, 
epinephrine, cortisol, and adrenaline (Moreno-Smith, Lutgendorf, & Sood, 2010).  
Investigation of human and mice cells have indicated that elevated levels of 
norepinephrine may result in metastasis and angiogenesis (Smith, Lutgendorf, & Sood, 2010). 
One study reported that immune response is effected by dopamine levels: “…DA depletion 
decreases T-cell responses and promotes tumor growth in mice” (Basu, Dasgupta, & 
Chowdhury, 1995). Studies have also revealed associations between increased psychosocial 
distress levels, relapse, and survival rates (Spiegel & Nemeroff, 1997). Elevated psychosocial 
distress levels are also associated with increased length of hospital stays, re-hospitalization costs, 
a patient’s desire for death, and morbidity and mortality rates (Allison et al., 1995; Pirl et al., 
2007). These findings emphasize the importance of assessing stress as it relates to clinical 
outcomes in cancer care.  
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Furthermore, since there is a continuum of psychosocial distress, many patients with 
milder subclinical manifestations may not meet strict diagnostic criteria for a mental illness. 
However, these individuals are experiencing valid, tangible, and illness-related bio-psycho-social 
symptoms that would benefit from supportive services. 
Institute of Medicine Report 
Supportive care for patients with cancer is a crucial action of oncology practice today. 
This movement is traced back to the transformative report by the Institute of Medicine, Cancer 
Care for the Whole Patient: Meeting Psychosocial Health Needs in 2007. This empirically and 
medically based report provided recommendations and guidelines for addressing whole person, 
integrative, and collaborative care for patients with a cancer diagnosis (Adler & Page, 2008; 
Institute of Medicine [IOM], 2007). The Institute of Medicine report addressed psychological 
problems associated with cancer and illness, the negative consequences of these unmet needs, 
and standard of care recommendations for cancer treatment settings to ensure that the 
psychosocial needs of  patients with cancer could be met and provided an opportunity for 
psychological services: “...good quality health  care must attend to patients’ psychosocial 
problems and provide services to enable them to better manage their illnesses and underlying 
health” (Institute of Medicine [IOM], 2007). Addressing psychosocial issues in cancer care has 
played a pivotal role in the advancement of oncology care since the release of this Institute of 
Medicine Report. Unfortunately, some physicians misjudge, undervalue, and overlook the 
significance of psychosocial distress in their oncological patients (Fallowfield, Ratcliffe, Jenkins, 
& Saul, 2001; Keller et al., 2004; Merckaert et al., 2005). Findings indicated that less than 30% 
of patient-physician interactions discuss psychosocial concerns and needs (Rodriguez et al, 2010; 
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Taylor et al., 2011). Oncologist’s clinical detection of depression has also been studied and 
findings have indicated a sensitivity rate of 29% and specificity of 85% (Fallowfield et al., 
2001).  The failure to detect and discuss these psychosocial concerns and problems in a patient 
suffering from a cancer diagnosis is a lost opportunity to provide them with well-rounded 
treatment and the ability to improve their overall quality of life. By thus targeting the “whole 
person” with high quality and multidisciplinary care, oncological services can improve treatment 
outcomes and potentially increase survival rates. 
American College of Surgeons Commission on Cancer Standards 
The recognition of psychosocial needs in oncology was further supported by the release 
of the American College of Surgeons (ACS), Commission on Cancer Standards 3.2 Psychosocial 
Distress Screening and 3.3 Survivorship Care Plan in 2015. The implementation date of these 
standards was January 1, 2015, and the imperative to meet that target for accreditation purposes 
motivated a new focus on patient-centered cancer care: one contingent on providing 
multidisciplinary approaches and comprehensive cancer care. These standards served as a 
foundation to effectuate psychosocial distress screening measures and survivorship care plans 
(SCPs) in accredited cancer sites (American College of Surgeons Commission on Cancer, 2012).  
The Survivorship Care Plan (SCPs) Standards mandated the implementation of a 
“…comprehensive care summary and follow-up plan to patients with cancer who are completing 
cancer treatment” (American College of Surgeons Commission on Cancer, 2012). The guidelines 
also recommended continued monitoring, documentation, and evaluation of the implementation 
process. The target behind SCPs are to better transition cancer survivors during their post 
treatment lives and to diminish negative outcomes that survivors experience, such as cancer-
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related fatigue or psychosocial distress. Areas of needs addressed by SCPs may include relevant 
information on their cancer type, treatment, follow-up appointments, access to community 
resources, coordination and transition to a primary care provider (PCP), lifestyle changes, 
screenings, and prevention (Daudt et al., 2014).  
 A majority of PCPs see the value and importance of SCPs. Research has indicated that 
PCPs felt better prepared in their treatment of cancer survivors, particularly in regard to the 
comprehensive nature of SCPs and the improvement of care coordination with specialty 
oncologists (Shalom, Hahn, Casillas, & Ganz, 2011). Patient benefits from SCPs have also been 
researched, with recent studies finding that patients reported satisfaction in the usability, value, 
and knowledge provided in the SCPs (Faul et al., 2012; Sparague et al., 2013). 
Despite much evidence and enthusiasm for implementation of the national standards, 
there have been some recent questions as to their benefit and efficacy.  For example, patients 
reported continued confusion with coordination of care even following the implementation of 
SCPs (Sparague et al., 2013). Recent research is also finding credible and primary concerns with 
implementation of SCPs: increased burden and workload on health care clinics, sustainability 
and feasibility issues, and utility for patient care (Faul et al., 2012). Furthermore, emerging 
research has found that SCPs are ineffective; one systematic review on SCPs found no 
significant or measurable benefits on psychosocial distress and cancer outcomes (Brennan, 
Gormally, Butow, Boyle, & Spillane, 2014). One response to the controversial evidence of the 
inefficacy of SCPs was a revised template issued by the American Society of Clinical Oncology 
(ASCO) Survivorship Care Plan Working Group.  The template minimized the “critical 
elements” required for SCP implementation and aimed to 1) increase adoption of SCP in clinical 
settings and 2) reduce resource load (Mayer, D.K., Birken, S.A., Check, D., & Chen, R.C., 
8 
 
2015). However, diminished and questionable efficacy of SCPs on survivorship raises the 
empirical question of how successful the implementations of the ACS Commission on Cancer 
Standards can be in oncology care.  
Psychosocial Distress Screening 
The Psychosocial Distress Screening Standard specified and mandated that health 
professionals engage in psychosocial screening in cancer settings and, in turn, the opportunity for 
psychosocial support, services, and resources following cancer treatment. Supportive care can be 
more streamlined to directly address each individual case by screening patients with cancer for a 
range of psychological, physical, and social needs in tandem with their cancer treatment. The 
guidelines mandated that screening should be offered to the cancer patient at least once during a 
medical visit, with the exact timing of said medical consultation to be decided by the facility. If 
screening reveals a moderate to severe psychosocial distress, the program must provide 
additional investigation into how “psychological, behavioral, and social problems of the patient 
may interfere with their ability to participate fully in their health care and manage their illness 
and its consequences” (“National Comprehensive Cancer Network,” n.d.). Most importantly, 
distress screening is tailored to target patients that are at high risk: those that present high levels 
of distress and are at an elevated risk for depression. Common distress screening tools include 
the NCCN Distress Thermometer (DT), Patient Health Questionnaire 9, Patient Health 
Questionnaire 2, Hospital Anxiety and Depression Scale, Beck Depression Inventory, and Brief 
Symptom Inventory (Vodermaier, Linden, & Siu, 2009). Monitoring cancer patient’s distress 
throughout their treatment and cancer course allows for higher quality oncology care and the 
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opportunity for early intervention for psychosocial related problems. This may entail a referral, 
consultation, or opportunity for services.  
The utilization of a standardized, validated instrument as a screening tool for cancer 
populations can have significant benefits: in the optimization of quality for patient-centered care; 
continuity of care; dissemination of information; optimization of treatment planning; identifying 
and discriminating risks; reduction of distress and barriers; devising cost-effective benefits; and 
providing a platform to address additional needs for services and interventions for the cancer 
patient. The optimal screening tool should assess the integrative needs of the patient, so as to 
provide a comprehensive assessment of all areas connected to their cancer diagnosis. This 
includes information about cancer, treatment, behavioral health changes, coping with financial 
situations, emotional consequences of cancer, proactive cancer management, occupational 
disruptions, practical problems, and familial/social impacts (“National Comprehensive Cancer 
Network,” n.d.).  
Since January 1, 2015, UF Health Cancer Center – Orlando Health has implemented 
routine and mandated psychosocial distress screening with the CancerSupportSource™ (version 
2.0) Program. The first patient visit at the clinics is devoted to the patient’s immediate medical 
needs, and on departure the psychological needs (support survey) are scheduled to commence at 
or prior to their return appointment. The patient may take the support survey online at home or 
onsite. An individualized “My Care Plan” is formulated from their responses and due to the 
Cancer Support Source Program’s action-based mission, patients are then provided with 
opportunities for a broad range of referral and supportive services (Buzaglo, Miller, Gayer, 
Morris, & Golant, 2013). Support groups, counseling, psycho- education, pain-management, 
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nutrition, and physical exercise can be addressed at the Cancer Support Community, Integrative 
Medicine Department at UF Health Cancer Center – Orlando Health. 
Relevant Studies on the CSS Program: Efficacy and Implementation in Community 
Settings 
The psychometric ability of the Cancer Support Source has been investigated with a 
community based sample of 319 cancer survivors. High internal consistency was illustrated with 
a Cronbach’s alpha of 0.91. Additionally, test-retest reliability of ICC ≥ 0.75 was found to be 
strong. The Cancer Support Source Program has also portrayed good concurrent validity and the 
strong ability to differentiate clinically significant groups with the Distress Thermometer (R(2) = 
0.35, p < 0.001), the Functional Assessment Scale of Cancer Therapy-General Well-Being Scale 
(R(2) = 0.58, p < 0.001), and the Center for Epidemiologic Studies Depression Scale (R(2) = 
0.48, p < 0.001) (Miller et al., 2012).   
An investigation of cancer survivors in a community-based Cancer Support Community 
utilized the Cancer Support Source screening program. The study reported that most patients 
experienced the highest level of distress within one year of their cancer diagnosis (p = 0.011) and 
had a significant risk for depression (p = 0.007). During this time the highest concern of patients 
with elevated levels of distress reported the desire to have discussions about their psychosocial 
needs. Patients over a year from their cancer diagnosis had a depression risk of 45% and also 
reported moderate to severe distress in areas such as worries about future, finances, and physical 
exercise (Buzaglo et al., 2016).  
Diverse racial-ethnic groups have also been evaluated utilizing the Cancer Support 
Source screening program to examine unmet needs and highest distress levels. Findings 
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indicated that Latinos had the most significant levels of distress (p = .004). Areas of greatest 
concern centered on treatment decisions and financial worries (Buzaglo et al., 2016).  
A previous research study has utilized the Cancer Support Source Program to examine 
test items that have the greatest discriminatory power by calculating the item discriminatory 
index (IDI) using low (≤ 4, n = 60) and high (≥ 13, n = 59) distress respondents with 251 cancer 
survivors at a community-based setting. Results showed that test items related to symptoms of 
depression, exhaustion, fears, nervousness, functional problems, worries about the future, and 
stressors (employment, academic, familial) had the greatest discriminatory power (IDI ≥ 0.8). 
Lowest discriminatory power was found with concerns associated with substance use, 
transportation, nutrition, and suicidal ideation (Miller, Mullins, Onukwugha, Golant, & Buzaglo, 
2014). The greatest discriminatory power found with the depression subscale is associated with 
items related to pain, meaning in life, and treatment decisions (Buzaglo, Miller, Golant, 
Longacre, & Kennedy, 2016). Findings such as these display the clinical importance of assessing 
areas of need to devote appropriate resources in cancer care for supportive services, referral, pain 
management, and assistance with treatment decisions.  
Preliminary research has investigated the single, existing depression subscale in the 
Cancer Support Source Program. This 4-item subscale is efficacious in screening and 
discriminating for depression risk. The depression subscale items ask the test respondent how 
concerned they are about feeling sad and/or depressed, feeling nervous or afraid, feeling lonely 
or isolated, and feeling too tired to do the things you need or want to do (see Appendix C).  The 
validation study found a 91% sensitivity in identifying depression risk in community based 
samples. Furthermore, rating five or more test items on a Likert scale 2 or greater will correctly 
recognize a patient requiring further intervention and assessment for depression (Buzaglo, 
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Miller, Gayer, Morris, & Golant, 2013). Additionally, the Cancer Support Source Program has 
been evaluated with the NCCN’S Distress Thermometer as a criterion.  The validation study, 
using the DT score greater than or equal to 4, found a 91% sensitivity and 49% specificity to 
“somewhat to very seriously concerned with 5 or more” other test items.  
Previous Multivariate Statistical Analyses on the Cancer Support Source Program  
Multivariate regression analyses have previously been performed on Cancer Support 
Source Program data. Specifically, procedures have examined descriptive concerns of patient 
responses and delved into topics such as ethnic groups with highest distress and an examination 
of depressive risk, time since cancer diagnosis, and distress levels.  
A previous investigation on the Cancer Support Source Program performed a limited 
regression analysis to identify ethnic groups (specifically Non-Hispanic White, African 
American, and Latino) with the greatest psychosocial distress levels. The multivariate regression 
analysis was adjusted for education, income, and age variables to examine the independent effect 
of minority ethnic groups on psychosocial distress, depressive symptomatology test items, and 
the chosen action to speak with a health professional to address concerns. Findings indicated the 
Latino ethnic group had significantly higher levels of distress when compared to the Non-
Hispanic White group and at a higher risk for depression compared to the Non-Hispanic White 
and African American groups. One implication of this study was the expressed need for factorial 
statistical analysis: “…future research should investigate factors that impact distress” (Buzaglo, 
Miller, Kennedy, Longacre, & Golant, 2016).  
An additional research study on the Cancer Support Source Program also utilized a 
multivariate regression analysis to identify and delineate unmet psychosocial concerns of 
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patients at varying points of cancer diagnosis. The adjusted regression analysis examined age, 
distress levels, specific concerns, and the screening response to speak to a health professional 
about their concerns. This study also expressed a desire for future investigative procedures of 
factors within the test-items: “…identify factors that predict those at greatest risk for ongoing 
and persistent distress” (Buzaglo et al., 2016). 
To date, there have been no explorations on subgroupings and subscales of the test items 
in the Cancer Support Source Program, such as physical, psychosocial, and practical. The 
purpose of this study is to determine whether there are underlying relationships between the test 
items in the Cancer Support Source Program, and to thus identify domains of need that can be 
the basis of improved care for patients with cancer.  Individual test items in the Cancer Support 
Source Program are helpful, but there may be an additional benefit to grouping and identifying 




CHAPTER THREE: METHODOLOGY 
Measure  
The Cancer Support Source Program has demonstrated validity and reliability in 
psychometric studies. This computer and Web-based program contains 25-items and is time-
limited and compliant with The Health Insurance Portability and Accountability Act (HIPPA). 
The Cancer Support Source Program is also easily accessible for patients, where they can 
complete the survey onsite at their medical visit on a tablet or online at home (Buzaglo, Miller, 
Kennedy, Longacre, & Golant, 2016). Test items are formulated on a 5-point Likert scale and 
ask respondents to rate their current concern severity level from 1(not at all) to 5(very seriously). 
The Cancer Support Source Program test items target multiple needs and symptoms of the 
patients, and include: nutrition, transportation, sexual problems, sleep, fatigue, emotional coping, 
worries, exercise, body image, mobility, treatment, and finances and their desire for assistance in 
a brief, concise, and timely manner (see Appendix C). Furthermore, the Cancer Support Source 
Program contains companion items which allow the patient to choose the level of action and 
need for services to address their distress: talk to a health professional, receive printed resources, 
or other information available as online materials (Vodermaier, Linden, & Siu, 2009). 
Participants 
Participant data was obtained from an archival data set taken from the Cancer Support 
Source Program implemented across the UF Health Cancer Center – Orlando Health clinics by 
the Integrative Medicine Department. UF Health Cancer Center – Orlando Health has cemented 
itself in excellence: it is in the top five national academic cancer sites, is the largest and most 
comprehensive cancer program in Florida, and has Commission on Cancer accreditation. 
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Furthermore, the UF Health Cancer Center – Orlando Health is designated by the state as the 
only cancer center of excellence in Central Florida. There have been no investigative procedures 
performed on Cancer Support Source data housed at a hospital setting, as the primary and 
prevalent usage of the Cancer Support Source Program has been in community and stand-alone 
sites.  
The research study was exempted by the Institutional Review Board at UF Health Cancer 
Center – Orlando Health. An approval letter confirming this exemption can be found in 
Appendix A. Additionally, a letter from UCF’s Institutional Review Board can be found in 
Appendix B. No identifying PHI was utilized in this research endeavor. The original archival 
data set was approximately 1000 patient data entries. The N of 1000 was cleaned for data 
analysis and the resulting N was comprised of 719 patient data entries. For the purpose of this 
study, the data set was split into two randomized subsamples (Group 1, N = 336; and Group 2, N 
= 383), and an analysis of one randomized sample group (Group 1, N = 336) was used in this 
exploratory research endeavor.  The second randomized sample group (Group 2, N = 383) of the 
Cancer Support Source Program patient data entries will be used in a future study (Confirmatory 
Factor Analysis).  The exploratory analysis (EFA) performed in this research study will be a 
template for future procedures and statistical analyses on the test items and patient data responses 
from the Cancer Support Source Program. Only completed, online, or onsite distress information 
from January 1, 2015 to December 31, 2015 was utilized and analyzed for this research study. 
This patient data set included cancer location, patient gender, and responses on the test items in 
the Cancer Support Source Program. 
Participants completed the distress screening, as this is a standard of clinical care, and a 
retrospective study examining archival data. As such, the completion of the distress screening 
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would represent the wish of the subject to participate in the best interest of their clinical care, and 
this data will be used to improve this care.  
Justification of Factorial Techniques 
For the purpose of this study, an exploratory factor analysis (EFA) was conducted to 
analyze underlying and inter-correlated factor groupings of the test items in the Cancer Support 
Source Program. The EFA statistical technique is appropriate due to the investigative nature of 
this study: to determine and extract groupings of test items to understand patient areas of need in 
cancer care targeted by the Cancer Support Source Program. There are neither prior assumptions 
nor expectations on the theoretical latent dimensions and constructs of the test items in the 
Cancer Support Source Program. This was an exploratory and heuristic endeavor.    
The implementation date of the American College of Surgeons Commission on Cancer 
Standards 3.2 at UF Health Cancer Center – Orlando Health utilizing the Cancer Support Source 
Program began on January 1, 2015.  Therefore, data analysis began with 336 archived patients 
over a calendar year:  starting on January 1, 2015 to December 31, 2015. Research findings 
delineate varying recommendations on sample sizes for an EFA. One guideline advised having at 
least a sample size of 300 and another study reported that a suitable sample size is greater than 
100 (Hair, Anderson, Tatham, & Black, 1995; Tabachnick & Fidell, 2007). Researchers Comrey 
and Lee categorize sample sizes of “…100 as poor, 200 as fair, 300 as good, 500 as very good, 
and 1000 or more as excellent…” (Comrey, 1973; Williams, Onsman, & Brown, 2014). 
Therefore, it can be argued that the data set utilized for this analysis is large enough to 
adequately perform an EFA.   
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Sample variable ratio (N:p) recommendations have been evaluated in exploratory factor 
analysis research findings and guidelines; with ambiguity concerning what sample variable ratio 
is optimal. Ranges of sample variable ratios include: “3:1, 6:1, 10:1, 15:1, or 20:1” (Comrey, 
1973; Everitt, 1975; Gorsuch, 1983; Guadagnoli & Velicer, 1988; Pett, Lackey, & Sullivan, 
2003; Sapnas & Keller, 2002; Swisher, Beckstead, & Bebeau, 2004; Tabachnick & Fidell, 2007; 
Thompson, 2004). One previous research study examined the influence of sample size on a data 
set’s ability to produce reliable factor solutions (Costello & Osborne, 2005).  Findings indicated 
that 70% of sample variable ratio data set of 20:1 produced reliable and statistically meaningful 
factor solutions and resulted in less misclassification of factors (Costello & Osborne, 2005). The 
sample variable ratio is approximately 13:1. Therefore, the sample variable ratio is justified to be 
adequate for the multivariate statistical analysis and enhances the probability of extracting 
meaningful and interpretable factor solutions (Stevens, 2002).  
The Cancer Support Source Program archival data set contains 25 test items in which an 
extraction of factor groupings was made from the sample size of 336.  The two randomized 
subsamples (Group 1, N = 336; and Group 2, N = 383) were randomized utilizing demographic 
variables, a p = .1, and repeated trials to uphold the randomized integrity of the two subsamples. 
Cross validation, Eigenvalues, scree plots, and a rotational method procedure was used to extract 
a factor structure of the test-items and to reveal test items loading on the same factors of these 
two sample groups (see Chapter Four: Results). 
Research literature on EFAs promote a variety of approaches to factor extraction; these 
include: principle components analysis (PCA), principal axis factoring (PAF), alpha factoring, 
maximum likelihood, un-weighted least squares, generalized least squares, image factoring, and 
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canonical (Tabachnick & Fidell, 2007; Thompson, 2004). The factors were extracted utilizing 
the PCA method.  
Findings have indicated disparate opinions on the statistical integrity of utilizing a PCA 
for a factor analysis. Some statistical research discusses that conducting a PCA extracts 
components and not factors, thereby concluding that it is not a true factor analysis procedure 
(Tabachnick & Fidell, 2007). However, many researchers have determined that utilizing a PCA 
is synonymous to other factorial extraction statistical techniques and will produce nearly 
analogous factor loadings. Our theoretical reasoning behind utilizing a PCA is due to its data 
reduction ability and its inclusion of both shared and unique variances (Costello & Osborne, 
2005).  A PCA analysis also assumes redundancy within variables; hence there is a possibility 
that variables are correlated and measuring a similar construct, i.e. areas of need in the Cancer 
Support Source Program test items. In this regard, we were able to reduce the variables in our 
data set to a more parsimonious number of principal components. Furthermore, a PCA analysis 
does not take into account a prior notion of underlying latent variables, which aligns with the 
exploratory research question.   
Factor extraction was based upon multiple criteria, as it is recommended “no single 
criteria should be assumed to determine factor extraction” (Costello & Osborne, 2005). 
Therefore, an analysis of both the Scree plot and eigenvalues was made to determine the amount 
of factor solutions to retain. The utilization of a Scree Plot with eigenvalues resulted in a visual 
representation of the possible number of factor solutions (point of diminished return or elbow). 
Research has demonstrated that a Scree Plot is reliable to use on data sets with a sample size of 
200 or above. Thereby we can justify that the subsample group (N = 336) exemplified an 
adequate sample size to feasibly use a Scree Plot. The “Total Variance Explained” in the SPSS 
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output and the natural break of the Scree Plot curve was examined to determine retainable 
factors.  Statistical recommendations emphasize that only rotated and extracted data are 
meaningful for interpretation, thus an evaluation of eigenvalues and variances was made after a 
rotational method has been performed. Specifically, this interpretation was made using the SPSS 
output Total Variance Explained (see Table 1) (Yong & Pearce, 2013).  
Multiple analyses were run to diminish possibly subjectivity of this visual inspection test: 
this will allow us to retain factors in a manual fashion and to objectively conclude the numerical 
quantity of factors in the data set sample groups (Costello & Osborne, 2005).  Data extraction 
will be supported by these multiple repeated procedures due to the complex, dynamic nature of 
interpreting factorial analyses results. Therefore, multiple approaches to our factor extraction 
were utilized to 1) avoid subjectivity in interpretation of results and 2) avoid possible errors or 
oversights and 3) justify the quantity of meaningful factors within our data set.  
A rotational method was utilized to “…maximize high item loadings and minimize low 
item loadings” (Williams, Onsman, & Brown, 2014) to combat the possibility of specific test 
items in the Cancer Support Source Program relating to more than one factor grouping 
(Williams, Onsman, & Brown, 2014). A factorial rotational method is useful in initial factor and 
dimension extraction because it identifies “simple and interpretable factors” (Yaremko, Harari, 
Harrison, & Lynn, 1986).  
Research findings indicate that oblique and orthogonal rotational methods may produce 
nearly identical and conceptually similar results (Costello & Osborne, 2005). However, statistical 
literature demonstrates that the selection of a specific rotational method is contingent on the 
nature of factors being correlated (oblique rotational method) or uncorrelated (orthogonal 
rotational method). Findings recommend to initially employ an oblique rotational method to 
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determine the optimal rotational procedure to perform on the data set. A manual entry input of 
the hypothesized desired number of factors with an oblique rotational method will result in a 
degree of correlation within the data set. Hence, the notion here is to guide researchers in 
determining the necessity of performing an orthogonal rotation on the data set (Brown, 
2009).This method was employed to analyze the degree of correlation in our data set and to 
guide our choice of a specific rotational method. As per recommended by statistical researchers 
Tabachnick and Fiddell, an analysis of the degree of correlation within our data set was made. 
Correlations around .32 or above were interpreted as merit for the utilization and justification of 
an oblique rotational analysis, due to the 10% variance overlap. However, if the data set had not 
contained correlational factors, then an orthogonal rotational method in our statistical analysis 
would have been pursued for final factorial interpretation (Tabachnick & Fidell, 2007). This 
methodology was utilized to enhance the credibility and feasibility of our decision to use the 
specific rotational method in this statistical analysis.  
Statistical findings were interpreted in a meaningful and theoretical fashion. High factor 
loadings were analyzed to adequately identify the strength of relationships within test items to 
group test items into factors. Additionally, an identification of low and zero factor loadings with 
minimal relationship strength confirmed and justified our factor groupings. A cut-off of .32, two-
tailed alpha level of 0.1, and the rotated factorial procedure was used to make statistically 
meaningful and reliable interpretations of the factor loadings (Tabachnick & Fidell, 2007; Yong 
& Pearce, 2013).  
There is a definite paucity in the Cancer Support Source Program literature of a 
multivariate statistical analysis on the specific test items. The key conceptual basis here is to gain 
further knowledge on the nature of the factors within these test items. The statistical results will 
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demonstrate 1) grouping test items into specific areas of need utilizing factor extraction, 2) 
display specific descriptive findings on factors scores, and 3) will be a basis for improvement in 
the Cancer Support Source Program.  The findings from this study will also disseminate vital 
information on factor groupings within the test items; which will generate future research on 
underlying subscales and hence provides a foundation for the confirmatory factor analyses 
procedure (CFA). Conducting an EFA on the Cancer Support Source Program test items 
provides meaningful and relevant information on psychosocial distress screening results to 
differentiate patient areas of need in a more parsimonious and valid fashion.  The results of our 
multivariate statistical analysis (see Chapter 4: Results) can be the basis to improve the 
interpretation of the Cancer Support Program screening results to better prioritize and improve 







CHAPTER FOUR: PROCEDURE 
The total data set of 719 was randomly split into two subsamples (Group 1, N = 336; and 
Group 2, N = 383). The first sample group was used in this study, while the second sample group 
was retained for future research to cross-validate the findings presented here.  Univariate outliers 
were retained in the data set due to the research interest of assessing respondents with extreme 
responses to different items.  
The two sample groups were compared to ensure that they were not significantly 
different on the available measures and to determine if the random split was successful.  Chi 
square tests were conducted to determine if any significant differences between the two 
randomized sample groups existed in the categorical data. Indeed, no significant differences were 
found between the two randomized groups concerning the frequency of gender χ
2
 (2, N = 719) = 
2.65, p =.27, depression risk χ
2
 (1, N = 719) = 0.00, p =.99, and cancer location χ
2
 (11, N = 719) 
= 10.96, p =.45.  Next the ordinal items from the two randomized groups were compared. 
Independent samples Mann-Whitney U Tests were conducted on the 25 items from Cancer 
Support Source questionnaire for the two randomized sample groups. Results from the individual 
Mann Whitney U tests did not find significant differences between groups on any of the 25 items 
on the Cancer Support Source questionnaire.  Since no evidence for differences between the 
groups existed on any categorical or ordinal measure, the randomization was deemed successful. 
The subsequent analyses and narrative for this thesis is based on the first sample group. The 
second sample group will be utilized in future efforts to cross validate the findings obtained here 




Initially, there were 336 patients in the group one sample data set. This data set was 
reviewed for missing data. Patients with three or more item non-responses were eliminated (N = 
19). Those with two, or less missing responses (N = 58) were retained in data set and mean 
replacement was used for the missing items. Therefore, the final data set used here included 317 
patients.  The top five most common missing responses were the items: “finding meaning and/or 
purpose in life” (n = 12), “managing side effects of treatment” (n = 10), “intimacy, sexuality 
and/or fertility” (n = 10), “feeling irritable” (n = 11), and “pain or physical discomfort” (n = 11).  
Statistical Methods 
All statistical analyses were conducted in SPSS Version 23. Exploratory factor analyses 
(EFA) were conducted on the data set as the primary statistical analytical procedures. The 
specific EFA chosen was Principal Component Analysis (PCA). Specifically, Tabachnick and 
Fidell (2013) recommend using a PCA to discover latent dimensions within a set of variables in a 
descriptive manner, as is consistent with the aims of the current study. Two PCA’s were 
conducted to ascertain the stability of the results. In the first PCA an oblique rotational procedure 
(Promax) was conducted and in the second an orthogonal rotational procedure (Varimax) was 
used. The Promax rotation is indicated when the factors are likely to correlate, it is expected that 
the factors extracted in this current study would exhibit correlation due to their relation with 
distress. Furthermore, Promax rotation is recommended due to its conceptual simplicity, 
expedient nature with larger data sets, and its ability to achieve a simple structure. In 
comparison, the Varimax rotation is recommended for non-correlation driven factors, offers 
simplicity in interpretation, and allows for maximization of the variance of the factor loadings 
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(Abdi & Williams, 2010). The factor solutions obtained by the two approaches revealed few 
differences in the factor structure and resulting item loadings as determined by the variance 
accounted for and the Eigenvalues. Since the factors on the Cancer Support Questionnaire are 
expected to correlate, the final factor solution is presented and interpreted with the Promax 
rotation.  
Results 
The appropriateness of the data set for EFA was examined in several ways.  Tabachnick 
and Fidell (2013) recommend that a minimum value for the KMO index (ranging from 0-1) of 
0.6 to conduct an adequate factor analysis.  The KMO index for this data set was 0.93, which 
indicates the data set is well-suited for factor analytic analysis.  Bartlett’s Test of Sphericity was 
significant (
2 
(300) = 3620.54, p < .05), therefore the null hypothesis that the correlation matrix 
is an identity matrix was rejected, also indicating that the dimensions of the data set can be 
reduced (Appendix E). Additionally, all diagonal items in the anti-image correlation matrix met 
the recommended criteria of above 0.5, indicating that all items could be retained for factor 
analysis. The extracted factors were evaluated to determine the percentage of variance, e.g. 
communalities. The recommended minimum value for communalities (0.30-0.40) was met, 
confirming that the data set test items had adequate shared common variance and relation with 
extracted factors and could all be retained for subsequent analysis (see Appendix G). Tabachnick 
and Fidell (2013) criteria also suggest that an adequate factor model will present with less than 
50% of non-redundant residuals with an absolute value greater than 0.5, which is confirmed in 




The PCA with Promax rotation produced five extracted factors with Eigenvalues (greater 
than 1). The first factor explained 38.17% of the variance, the second factor 5.65% of the 
variance, the third factor accounted for 5.52 % of the variance, the fourth factor accounted for 
4.66% of the variance, and the fifth factor accounted for 4.21% of the variance. The five 
extracted factors accounted for 58.20% of the cumulative variance (see Table 1).  
Table 1 Total Variance Explained with Principal Component Analysis with Promax Rotation 
with Kaiser Normalization 
 
Note. When components are correlated, sums of squared loadings cannot be added to obtain a total variance. 
The structure matrix suggested five factors for interpretation (see Table 2).  The structure 
matrix was the primary matrix utilized for interpretation due to its ability to find correlations 
between factors and variables (Beavers et al., 2013; Rietveld & Van Hout, 1993). However, the 
 















1 9.54 38.17 38.17 9.54 38.17 38.17 8.12 
2 1.41 5.65 43.82 1.41 5.65 43.82 6.83 
3 1.38 5.52 49.33 1.38 5.52 49.33 5.75 
4 1.17 4.66 53.99 1.17 4.66 53.99 3.34 
5 1.05 4.21 58.20 1.05 4.21 58.20 1.10 
6 .93 3.72 61.92     
7 .88 3.51 65.42     
8 .79 3.18 68.60     
9 .77 3.06 71.66     
10 .75 3.00 74.66     
11 .66 2.65 77.31     
12 .65 2.58 79.89     
13 .60 2.39 82.28     
14 .55 2.19 84.47     
15 .53 2.11 86.58     
16 .49 1.97 88.54     
17 .45 1.79 90.34     
18 .43 1.70 92.04     
19 .37 1.46 93.50     
20 .35 1.39 94.89     
21 .32 1.28 96.17     
22 .28 1.11 97.28     
23 .26 1.05 98.33     
24 .22 .89 99.21     
25 .20 .79 100.00     
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pattern matrix was also consulted to reveal replicability and consistency across factor loadings 
within the extracted factors. A visual inspection of the structure matrix indicated high factor 
loadings for five factors
1
: Factor 1 (Distress) 9 items, Factor 2 (Treatment Decisions and 
Management) 8 items, Factor 3 (Lifestyle) 5 items, Factor 4 (Relationship) 2 items, and Factor 5 
(Substance Use) 1 item.  
Table 2 Structure Matrix: Factor loadings and Communalities Based on a Principal Component 
Analysis with Promax with Kaiser Normalization Rotation for 25 items from the Cancer Support 
Source Questionnaire (N = 317) 
Item Component   
1 2 3 4 5 
1 .320 .550 .537 .379 -.196 
2 .660 .311 .507 .425 .154 
3 .359 .283 .808 .133 .189 
4 .339 .633 .466 .195 .181 
5 .538 .320 .570 .358 .118 
6 .639 .657 .402 .483 .024 
7 .864 .443 .477 .378 .032 
8 .332 .558 .205 .136 .405 
9 .654 .482 .650 .060 .184 
10 .557 .601 .399 .389 -.199 
11 .854 .473 .413 .251 -.028 
12 .840 .556 .462 .234 -.023 
13 .553 .754 .320 .184 .110 
14 .369 .442 .255 .796 -.051 
15 .733 .418 .412 .449 .124 
16 .514 .485 .457 .317 .141 
17 .310 .188 .196 .794 .134 
18 .629 .411 .709 .220 .022 
19 .691 .734 .407 .149 -.017 
20 .689 .588 .348 .304 .127 
21 .362 .473 .603 .215 -.380 
22 .488 .647 .728 .303 -.225 
23 .199 .166 .165 .160 .655 
24 .341 .707 .340 .305 -.087 




                                                     
1
 The factor labels are based on visual inspection of the highest loading items in a factor. 
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A visual inspection of the Scree Plot indicated a leveling off (the elbow) of Eigenvalues 
after five extracted factors, however visual interpretation of the graph was difficult since the first 
extracted factor explained a disproportional amount of the variability in the data set (see Figure 
1). Due to the subjective nature of interpreting the Scree Plots, and since factors 2 through 5 
explained a significant amount of variance and were theoretically coherent, emphasis was placed 
on the structure and pattern matrix in order to determine the appropriate number of extracted 
factors. 
 
Figure 1 Scree Plot of Eigenvalues and Component Numbers 
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Nature of Factors 
Two methods were used to demonstrate adequate discriminant validity for the five 
extracted factors. First, the structure matrix was evaluated to extrapolate variables loading 
significantly on one factor and to ensure that no significant cross-loadings were occurring (see 
Table 2). Second, the component correlation matrix was examined to ensure that factor 
correlation did not exceed 0.7 (see Table 3). Sufficient face validity was found indicating that 
items loading on the same factor made conceptual sense. For example, items loading in the 
Treatment Decisions and Management Factor centered on communicating with your doctor, 
transportation, managing side effects of treatment (such as body image), decisions about 
treatment, and finding reliable information about treatment.  
Table 3 Correlations Among Components with Principal Component Analysis with Promax 
Rotation with Kaiser Normalization  


































Internal consistency of the extracted factors was examined by conducting a reliability 
analysis with Cronbach’s Alpha.  The Distress Factor had a Cronbach’s Alpha of 0.89, the 
Treatment Management and Decisions Factor had a Cronbach’s Alpha of 0.83, the Lifestyle 
Factor had a Cronbach’s Alpha of 0.76 and the Relationship factor had a Cronbach’s Alpha of 
0.62. A Cronbach’s Alpha for the Substance Use Factor could not be computed because it was a 
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single-item factor. The Cronbach’s Alpha for the first three factors would be classified as 
acceptable values for a reliability coefficient (George & Mallery, 2003; Tavakol & Dennick, 
2011). 
Each factor was treated as a subscale score for each patient by totaling the item scores 
and dividing by the number of items (with the exception of the last factor which only had a 
single item). These factors were computed into subscales and are collectively called the Concern 
Subscales. Table 4 presents the items for each subscale on the Cancer Support Questionnaire. 
Table 5 presents the correlations between the 5 subscale scores. 
Table 4 Cancer Support Source Item Composition for Five Concern Subscales  
Scale 
Item Number on Cancer Support Source 
Questionnaire 
Distress 2, 7, 9, 11, 12, 15, 16, 20, 25 
Treatment Management and Decisions 1, 4, 6, 8, 10, 13, 19, 24 
Lifestyle 3, 5, 18, 21, 22 
Relationship 14, 17 
Substance Use 23 
Note. Cancer Support Source Questionnaire test items can be found in Appendix C.  
 
Table 5 Pearson Correlations Among Five Concern Subscales of Cancer Support Source 
Questionnaire 
 
 Distress Treatment Lifestyle Relationship 
Treatment .74
**


























Note. **. Correlation is significant at the 0.01 level (2-tailed). *. Correlation is significant at the 
0.05 level (2-tailed). 
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Comparing Cancer Support Source Questionnaire Subscales by Cancer Location 
Patients were assigned to cancer location groups. Patients fell into one of 12 cancer 
classifications: breast, blood, lung, head and neck, gynecologic, gastrointestinal, skin, prostate, 
liver, brain and spine, pancreatic, and multiple locations.  Cancer groups which had an N greater 
than 20 were retained to compare Cancer Support Group Questionnaire Concern subscales by 
cancer location. These four groups were breast, head and neck, lung, and gynecologic cancer. 

























































































Note. Standard deviations appear in parentheses below means.  
 
The scores on the five subscales of the Cancer Support Source Questionnaire for these 
four cancer groups were compared with MANOVA. No significant multivariate differences were 
found by group, Wilk’s Lambda F(15, 621) = 1.55, p < .08, η
2
 = .03.  Univariate tests of effects 
were conducted separately for each subscale by group and revealed that the Lifestyle subscale 
score approached significance, F(3) = 2.578,  p < .06, η
2
 = .03.  Ad hoc tests were then 
conducted to identify where the trends were for the cancer groups to differ. Indeed, Tukey’s 
HSD revealed two significant differences at the p < 0.05 level. The Breast Cancer group’s 
Lifestyle scores were higher than the Gynecologic Cancer group, and the Breast Cancer group 




Figure 2 Bar graph of lifestyle subscale by cancer locations breast, lung, head and neck, and 
gynecologic 
Comparing Cancer Support Source Questionnaire Subscale Action Items by Cancer 
Location 
 On the Cancer Support Source Questionnaire there is a column of companion items 
corresponding to the concern items asking the patient to choose the level of action they wish to 
receive (see Appendix C). These questions are called “Action” items. These companion 
questions have the header “Please let us know how we can help you...” The three response 
options for each item in this column are: “Have a staff person talk with you,” “Provide you 
additional information,” or “No action needed.” Thus for each item identifying a specific 
concern of the patient, they can indicate whether they require additional personalized attention 
on that topic.  
In order to develop a scoring system for the four subscales with two or more action items, 
each occurrence of a response indicating no action was required was counted as a “0.”  Secondly, 
each occurrence of a response indicating wanting more information was counted as a “1.” Lastly, 




















each occurrence of a response indicating wanting a staff person to talk with them was counted as 
a “2.” These scores were then summed within subscales and represented the “Action” score for 
that subscale. The mean and standard deviation of this count by Cancer Location is presented in 
Table 7.  
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Breast 
























































Note. Standard deviations appear in parentheses below means.  
 
Next the four Cancer Support Source Subscale Concern Scores were correlated with 






Table 8 Pearson Correlation between Cancer Support Source Subscale Concern Scores with 
Subscale Action Scores 














































































































Note. **. Correlation is significant at the 0.01 level (2-tailed). 
 
The four Subscale Action Scores for each of the Cancer Location groups were contrasted 
using separate univariate ANOVAs and no significant differences were obtained. 
Comparing Depression Subscale with Distress Concern Subscale 
 The item loadings on the Distress Concern Subscale were investigated to ascertain if 
these items correspond to the 4-items that comprise the existing depression subscale: 7, 11, 15, 
and 18(see Appendix C). The Distress Concern Subscale did indeed contain three of the items 
that are contained in the depression subscale: 7, 11, and 15. These three items also demonstrated 
35 
 
the highest item loadings on the Distress Concern Subscale with item loadings .864, .854, and 
.744, respectively. A high correlation was found between the depression subscale and the 
Distress Concern Subscale, r(315) = .91, p < .01. A one-way ANOVA was conducted for the 
four cancer location groups (breast, lung, head and neck, and gynecologic cancer) and the 






CHAPTER 5: DISCUSSION 
The EFA (Principal Component Analysis) conducted on the Cancer Support Source 
Program test items yielded a five factor structure solution, adequate psychometric properties, and 
the promise of clinical utility. Specifically, two EFA’s (one performed with an oblique rotation 
and one with an orthogonal rotation) were conducted to replicate the solution across procedures. 
Additionally, both the structure and pattern matrix were interpreted for resulting item-loadings to 
demonstrate that factor extraction and dimension composition were consistent.  
The PCA, conducted with Promax rotational procedure was used as the basis for 
interpretation. It yielded five factors with eigenvalues greater than 1 which were retained and 
extracted. The five factors were labeled using the highest loading item on that factor as a guide. 
Items on each factor were coherent and the interpretation was straightforward indicating good 
face validity. These factors were computed into subscales and are termed the Concern subscales. 
Each factor was labeled as follows:  Distress (Factor 1), Treatment Management and Decisions 
(Factor 2), Lifestyle (Factor 3), Relationship (Factor 4), and Substance Use (Factor 5). Due to the 
few items loading on the Relationship factor and Substance Use factor (2-item and 1-item 
loadings respectively), only the Distress, Treatment Management and Decisions, and Lifestyle 
Factors could be evaluated for internal consistency with Cronbach’s Alpha. The internal 
reliability of those 3 subscales was found to be good to very good.   
A further analysis of the five extracted factors indicated that the first factor, Distress 
Factor, accounted for 38.17% of the variance and the greatest number of high item loadings (9-
item loadings). In comparison, the Treatment Management and Decisions Factor (8-item 
loadings) accounted for 5.65% of the variance, the Lifestyle Factor (5-item loadings) accounted 
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for 5.52% of the variance, the Relationship Factor (2-item loadings) accounted for 4.66% of the 
variance, and the Substance Use Factor (1-item loading) accounted for 4.21% of the variance. 
 A visual inspection of the Scree Plot was less informative in suggesting the correct 
number of factors.  The scree plot suggested the data were primarily driven by distress and less 
by secondary concerns related to treatment, lifestyle, relationship problems, and substance use.  
Nonetheless, the scree plot confirms that the Cancer Support Source Program significantly 
captures symptoms and concerns related to distress, which supports the use of the Cancer 
Support Source as a psychosocial distress screening instrument in a heterogeneous population of 
patients with cancer.  
A recent study applied an exploratory factor analysis (EFA) to the 29-item Cancer 
Problems in Living Scale (CPILS) with a very large data set of patients with heterogeneous 
cancer types (Zhao et al., 2009). These researchers identified a 3, 4, and 5 factor solution from 
their EFA. Their 5 factor solution resulted in the following subscales: 1) physical distress; 2) 
emotional distress; 3) employment/financial problems; 4) friends and family relations; and 5) 
fear of recurrence. Four of their five subscales or factors are similar to what was found in this 
study utilizing an EFA on the Cancer Support Source Questionnaire. The exception being that 
the researchers found a fear of recurrence factor and our EFA findings found a substance use 
factor. It is important to note that the CPILS does not contain Action items to direct the clinician 
to provide specific services. 
Subscale Findings by Cancer Location 
Patients in this sample were divided into groups by the location of their cancer. Four 
cancer location groups were sufficiently large to statistically compare to one another. They were 
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breast, head and neck, lung, and gynecologic cancer. No significant multivariate differences on 
the MANOVA were found between cancer group locations and the five subscales. However, 
since the Lifestyle Factor approached significance on the multivariate F test (p = .06), ad hoc 
tests were conducted for this subscale by these four cancer locations. Two significant differences 
emerged with ad hoc testing. That is, the Breast Cancer group’s Lifestyle scores were higher than 
the Gynecologic Cancer group, and lower than the Lung Cancer group. These findings indicate 
that further research on the impact of cancer location on lifestyle issues is warranted. We are 
hopeful that future studies could replicate these findings and in addition, include more complex 
patient variables such as cancer type, stage of cancer, duration, and type of cancer treatment.  
Action Subscale Scores 
One of the features of the Cancer Support Source Questionnaire that distinguishes it from 
other illness impact questionnaires is the companion action items to each specific question of 
concern. We developed subscales for the Action items to examine whether there was any utility 
in summarizing parallel Action subscales with the factor scores described above.  This was 
accomplished by simply summing the Action items by subscale. It was found that the resulting 
Action subscales were highly correlated with their companion Concern subscales and provided 
little additional information for interpretation. Therefore, it is recommended that the action items 
be used as they are and not be arranged into subscales. As they stand, the Action items are an 
effective way to facilitate discussion and intervention with an individual patient.  
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Depression Subscale and Distress Concern Subscale 
 The extracted Distress Concern Subscale was found to be highly correlated with the 
existing 4-item depression subscale. This indicates there is a strong relationship between the 
Distress Concern Subscale found in this study and the existing depression subscale in the Cancer 
Support Source Program. These findings illustrate the Distress Concern Subscale may indeed 
capture symptoms of depression in addition to distress.  
Recommendations 
The Cancer Support Source Program as it is currently used allows the clinician to drill 
down to the very specific service needs of the individual patient.  In fact, the 25-items represent 
25 different potential services the patient may require.  From a psychometric perspective this 
approach is referred to as an ideographic approach. The Concern subscales developed here for 
the Cancer Support Source Program allows comparison of patient’s needs at a construct level of 
analysis. With this nomothetic approach, the patient’s level of distress in these five general areas 
of need may be evaluated and contrasted using normative values for different populations. That 
is, patients with extreme scores on one or more of the Concern subscales can be compared to 
other patients with that type of cancer.  As they stand, the single items of concern in the Cancer 
Support Source Program are useful, but they may fail to capture the complete meaning that a 
subscale can portray; Distress, Treatment Management and Decisions, Lifestyle, and 
Relationship factors are complex latent constructs with many facets and implications; a single 
item may miss the larger issue at hand. That is, single items may miss the forest for the trees. It is 
thereby recommended that the Concern subscales be used to inform clinicians in a heuristic 
manner. It is also recommended that the Action items be retained and used as currently indicated.  
40 
 
The Action items give the Cancer Support Source Questionnaire its unique and distinctive 
ideographic quality. Since the Concern subscales correlates highly with the Action items when 
they are summed into subscales, nothing is lost, and in fact the utility of the questionnaire is 
potentially expanded. This enhancement in clinical utility is also demonstrated with the high 
correlation findings between the Distress Concern Subscale and the existing depression subscale.  
The development of the Concern subscales produced by an exploratory factor analysis is 
easily scored. The item-composition of each of the subscales facilitates and targets parsimonious 
areas to discuss with the patient in cancer care. This allows for a greater breadth of information 
of potential areas of need to address with the patient and enhances the patient’s ability to 
ascertain valuable information and/or resources regarding their cancer care.  
Future Directions 
An area of improvement for the Cancer Support Source Program could be eliminating the 
2 or 3 items with lower loadings on the Distress Factor, and the 1 or 2 items with lower loadings 
on the Treatment Management and Decision Factor. This would shorten the questionnaire 
without affecting the reliability of those scales. This could also make room for creating and 
adding new items for the Relationship and Substance Use subscales. Since the Relationship and 
Substance Use factors could not produce internally consistent subscales with only 1 or 2 items, 
adding items to those scales will enhance their psychometric potential. Relationship and 
Substance Use issues are clinically relevant and important constructs for this population.  Adding 
items would enhance the reliability of the Relationship and Substance Use subscales and provide 
a more robust understanding of these specific areas of need in this clinical population.   
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The Substance Use subscale presents challenges for the settings that the Cancer Support 
Questionnaire is often used. While this subscale can identify patients that warrant referral for 
substance abuse intervention, not all community settings have access to such referrals. 
Furthermore, the definition of addiction in these settings requires consideration of individual 
disease factors and mortality considerations. Even in hospital settings, Cancer Survivor and 
Support services are not generally considered a mental health or addiction treatment service, thus 
this information gleaned from this subscale may need to be segregated to protected areas of the 
medical record. Nonetheless, whether in a hospital or community setting, the substance use 
question is important. Employing the Cancer Support Source Program can suggest additional 
screening for substance abuse and referral and/or intervention in as minimally intrusive manner 
as possible (Tai, Wu, & Clark, 2012).   
It is recommended the Concern subscale findings from this research study be used to help 
identify normative clinical cut-offs for the Cancer Support Source Program in future studies. As 
of now, cut-off scores for the Cancer Support Source Program are arbitrary and are determined 
individually by each site employing this instrument. The means and standard deviations for the 
Concern subscales by cancer location group reported in this study may contribute to the 
development of clinical cut-off recommendations.  
Lastly, the preliminary research presented here demonstrated an extracted factor model 
that was internally consistent and had adequate discriminant and face validity. Therefore, future 
studies should employ the factors found in this study as a template for further confirmatory 




Impact of Findings 
Assessing distress is a critical aspect of cancer care and many studies have indicated that 
well-being and quality of life have a significant impact on survival, treatment, and healing 
outcomes (Anderson, Kiecolt-Glaser, & Glaser, 1994). The findings presented here confirm the 
heterogeneous impact and prevalence of distress and quality of life factors in the cancer patient 
population. This study demonstrates how different distress factors are of primary concern in 
patients with various cancer locations. Finally, it contributes to the available tools for 
recognizing, screening for, and providing appropriate referral and services for patients with 
cancer in the areas of distress, treatment management and decisions, lifestyle, relationship, and 
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Today, how concerned are you about...? 
(Please circle one option) 
Please let us know how we 
can help you... 
(please check all that apply) 
1. Eating and nutrition 
1 2 3 4 5 
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
2. Feeling irritable 
1 2 3 4 5 
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
3. Moving around (walking, climbing stairs, lifting, etc.) 
1 2 3 4 5 
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
4. Communicating with your doctor 
1 2 3 4 5 
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
5. Sleep Problems 
1 2 3 4 5 
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
6. Changes or disruptions in work, school, or home life 
1 2 3 4 5 
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
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7. Feeling sad or depressed 
1 2 3 4 5 
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
8. Transportation to treatment and appointments 
1                   2       3              4         5 
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
9. Pain and/or physical discomfort 
1                   2       3              4         5 
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
10. Body image and feelings about how you look 
1                   2       3              4         5                     
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
11. Feeling nervous or afraid 
1                   2       3              4         5                    
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
12. Worrying about the future and what lies ahead 
1                   2       3              4         5                     
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
13. Making a treatment decision 
1                   2       3              4         5                    
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
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14. Intimacy, sexual function and/or fertility 
1                   2       3              4         5  
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
 
15. Feeling lonely or isolated 
1 2 3 4 5 
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
16. Health insurance or money worries 
1 2 3 4 5 
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
17. Problems in your relationship with your spouse/partner 
1 2 3 4 5 
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
18. Feeling too tired to do the things you need or want to do 
1 2 3 4 5 
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
19. Managing side effects of treatment (nausea, swelling, etc.) 
1 2 3 4 5 
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
20. Worrying about family, children and/or friends 
1 2 3 4 5 
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
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21. Recent weight change (gain or loss) 
1 2 3 4 5 
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
 
Today, how concerned are you about...? 
 
(Please circle one option) 
Please let us know how we 
can help you... 
(please check all that apply) 
22. Exercising and being physically active 
1 2 3 4 5 
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
23. Tobacco or substance use – by you or someone in your 
household 
1 2 3 4 5 
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
24. Finding reliable information about complementary or 
alternative practices 
1 2 3 4 5 
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
25. Finding meaning and purpose in life 
1 2 3 4 5 
Not at all Slightly Moderately Seriously Very Seriously 
□Have a staff person talk with you. 
□Provide you additional information. 
□No action needed. 
26. What type of cancer do you have? 
 Blood  Gynecologic Pancreatic 
 Brain and Spine  Head and Neck  Prostate
 Breast  Liver  Skin













Item Number Mean (M) Standard Deviations (SD) 
1 3.04 1.36 
2 2.17 1.22 
3 2.12 1.29 
4 2.12 1.41 
5 2.31 1.33 
6 2.25 1.29 
7 2.18 1.23 
8 1.61 1.09 
9 2.46 1.27 
10 2.11 1.21 
11 2.28 1.26 
12 2.68 1.30 
13 2.31 1.34 
14 1.59 1.05 
15 1.58 .98 
16 2.54 1.40 
17 1.29 .81 
18 2.38 1.23 
19 2.49 1.26 
20 2.16 1.26 
21 1.90 1.18 
22 2.39 1.26 
23 1.27 .85 
24 1.95 1.23 












of Sampling Adequacy. 
 .93 
Bartlett’s Test of Sphericity  Approx. Chi-Square 3620.54 
 Df. 300 























































































































































































































Note. Standard deviations appear in parentheses below means.  
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